Cardiff Oncology, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 41K | 243K | 120K | 121K | 109K | 151K | 165K | 163K |
| Cost of Goods Sold | 0 | 0 | 0 | 11.6M | 0 | 0 | 9.6M | 105K |
| Gross Profit | 41K | 243K | 120K | -11.5M | 109K | 151K | -9.5M | 58K |
| R&D Expenses | 6.8M | 5.1M | 8.2M | 11.6M | 10.5M | 9.7M | 9.6M | 9.5M |
| Operating Expenses | 12.9M | 8.1M | 12.1M | 3.3M | 14.5M | 12.7M | 3.1M | 12.6M |
| Operating Income | -12.8M | -7.8M | -12.0M | -14.8M | -14.4M | -12.6M | -12.6M | -12.5M |
| Other Income / Gains | 505K | 611K | 716K | 834K | 948K | 785K | 746K | 767K |
| Net Income | -12.3M | -7.2M | -11.3M | -13.9M | -13.4M | -11.8M | -11.9M | -11.8M |
| EPS (Diluted) | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 | -0.25 | -0.25 | -0.26 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 1.00 | 1.00 | -94.702 | 1.00 | 1.00 | -57.424 | 0.356 |
| General And Administrative Expenses | 6.1M | 3.0M | 3.9M | 0 | 4.0M | 3.0M | 0 | 2.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 459K |
| Selling General And Administrative Expenses | 6.1M | 3.0M | 3.9M | 0 | 4.0M | 3.0M | 0 | 3.2M |
| Other Expenses | 0 | 0 | 0 | -8.3M | 0 | 0 | -6.5M | -105K |
| Cost And Expenses | 12.9M | 8.1M | 12.1M | 14.9M | 14.5M | 12.7M | 12.8M | 12.7M |
| Interest Income | 506K | 612K | 716K | 835K | 941K | 787K | 741K | 805K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 221K | 223K | 494K | 94K | 228K | 96K | 101K | 105K |
| Ebitda | -12.1M | -7.0M | -10.8M | -13.8M | -13.2M | -11.7M | -11.8M | -11.7M |
| Ebitdaratio | -295.707 | -28.778 | -89.70 | -114.455 | -121.156 | -77.424 | -71.236 | -71.613 |
| Operating Income Ratio | -313.415 | -32.21 | -99.783 | -122.124 | -131.945 | -83.258 | -76.37 | -76.963 |
| Income Before Tax | -12.3M | -7.2M | -11.3M | -13.9M | -13.4M | -11.8M | -11.9M | -11.8M |
| Income Before Tax Ratio | -301.098 | -29.695 | -93.817 | -115.231 | -123.248 | -78.06 | -71.848 | -72.258 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -301.098 | -29.695 | -93.817 | -115.231 | -123.248 | -78.06 | -71.848 | -72.258 |
| Epsdiluted | -0.18 | -0.11 | -0.17 | -0.21 | -0.28 | -0.25 | -0.25 | -0.26 |
| Weighted Average Shs Out | 68.3M | 66.8M | 66.9M | 66.5M | 66.5M | 47.6M | 46.9M | 44.8M |
| Weighted Average Shs Out Dil | 68.3M | 66.8M | 66.9M | 66.5M | 47.6M | 47.6M | 46.9M | 44.8M |